EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro and In Vivo Evidence towards Fibronectin’s Protective Effects against Prion Infection

M Carmen Garza iD, Sang-Gyun Kang, Chiye Kim, Eva Monleón, Jacques van der Merwe, David A Kramer iD, Richard Fahlman, Valerie L Sim iD, Judd Aiken, Debbie McKenzie, Leonardo M Cortez, Holger Wille iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242417525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von M Carmen Garza und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, AB T6G 2M8, Canada. Hauptthemen laut MEDLINE: Fibronectins, Prion Diseases, Prions, Scrapie. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alberta Prion Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A distinctive signature of the prion diseases is the accumulation of the pathogenic isoform of the prion protein, PrPSc, in the central nervous system of prion-affected humans and animals. PrPSc is also found in peripheral tissues, raising concerns about the potential transmission of pathogenic prions through human food supplies and posing a significant risk to public health. Although muscle tissues are considered to contain levels of low prion infectivity, it has been shown that myotubes in culture efficiently propagate PrPSc. Given the high consumption of muscle tissue, it is important to understand what factors could influence the establishment of a prion infection in muscle tissue. Here we used in vitro myotube cultures, differentiated from the C2C12 myoblast cell line (dC2C12), to identify factors affecting prion replication. A range of experimental conditions revealed that PrPSc is tightly associated with proteins found in the systemic extracellular matrix, mostly fibronectin (FN). The interaction of PrPSc with FN decreased prion infectivity, as determined by standard scrapie cell assay. Interestingly, the prion-resistant reserve cells in dC2C12 cultures displayed a FN-rich extracellular matrix while the prion-susceptible myotubes expressed FN at a low level. In agreement with the in vitro results, immunohistopathological analyses of tissues from sheep infected with natural scrapie demonstrated a prion susceptibility phenotype linked to an extracellular matrix with undetectable levels of FN. Conversely, PrPSc deposits were not observed in tissues expressing FN. These data indicate that extracellular FN may act as a natural barrier against prion replication and that the extracellular matrix composition may be a crucial feature determining prion tropism in different tissues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibronectinsPrion DiseasesPrionsScrapieAnimalsHumansCell LineSheep

Stichwörter der Autor:innen

extracellular matrix (ECM)k fibronectinmusclemyotubeprionreserve cellsscrapietropism

Substanzen

FibronectinsPrions

Autor:innen und Institutionen

  • Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, AB T6G 2M8, Canada.
  • Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2H7, Canada.
  • Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9, Canada.
  • Centro de Encefalopatías y Enfermedades Transmisibles Emergentes, Departamento de Anatomía e Histología Humana, Universidad de Zaragoza, IA2, IIS Aragón, 50013 Zaragoza, Spain.
  • Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 1C9, Canada.
  • Department of Medicine, University of Alberta, Edmonton, AB T6G 2G3, Canada.

ORCID-Profile: M Carmen Garza, David A Kramer, Valerie L Sim, Holger Wille

Förderung

  • Alberta Prion Research Institute

Zitieren

APA

Garza, M. C., Kang, S. G., Kim, C., Monleón, E., van der Merwe, J., Kramer, D. A., Fahlman, R., Sim, V. L., Aiken, J., McKenzie, D., Cortez, L. M., & Wille, H. (2023). In Vitro and In Vivo Evidence towards Fibronectin’s Protective Effects against Prion Infection. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417525

Vancouver

Garza MC, Kang SG, Kim C, Monleón E, van der Merwe J, Kramer DA, et al. In Vitro and In Vivo Evidence towards Fibronectin’s Protective Effects against Prion Infection. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417525

BibTeX
@article{Garza2023,
  author = {Garza, M Carmen and Kang, Sang-Gyun and Kim, Chiye and Monleón, Eva and van der Merwe, Jacques and Kramer, David A and Fahlman, Richard and Sim, Valerie L and Aiken, Judd and McKenzie, Debbie and Cortez, Leonardo M and Wille, Holger},
  title = {In Vitro and In Vivo Evidence towards Fibronectin’s Protective Effects against Prion Infection},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242417525}
}
Kostenlos starten →